Cite
HARVARD Citation
Guigay, J. et al. (2017). Long-term response in patient with recurrent oropharyngeal carcinoma treated with cetuximab, docetaxel and cisplatin (TPEx) as first-line treatment followed by cetuximab maintenance. Oral oncology. pp. 114-118. [Online].